One of pharma’s biggest success stories in recent years and one of venture capital’s major players in the life sciences, Shire PLC and Atlas Venture, have agreed to a multi-year collaboration to incubate early-stage research programs for rare disease therapeutics.
Under the deal announced Dec. 15, representatives from Shire and Atlas will work together to vet research proposals worthy of...